Related Experiment Videos
Aspects of renal bone disease
Australian and New Zealand Journal of Medicine
|January 1, 1981
Summary
In chronic renal failure, low calcium (hypocalcaemia) results from reduced calcium in plasma and increased kidney loss. This can lead to bone density changes and osteomalacia in dialysis patients, possibly due to toxins.
Area of Science:
- Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Advanced chronic renal failure (CRF) presents complex mineral and bone disorders.
- Hypocalcaemia in CRF stems from decreased plasma calcium and increased renal calcium excretion.
- Secondary hyperparathyroidism is a common complication, impacting bone structure.
Purpose of the Study:
- To elucidate the multifactorial causes of hypocalcaemia in advanced chronic renal failure.
- To describe the skeletal consequences of secondary hyperparathyroidism, including osteosclerosis.
- To identify potential etiologies for atypical osteomalacia observed in dialysis patients.
Main Methods:
- Review of established pathophysiological mechanisms in chronic renal failure.
- Analysis of the relationship between hypocalcaemia, secondary hyperparathyroidism, and bone mineral changes.
- Observation and characterization of specific bone pathologies in the dialysis population.
Main Results:
- Hypocalcaemia in advanced CRF is attributed to reduced calcium delivery to plasma and enhanced renal tubular calcium leakage.
- Secondary hyperparathyroidism contributes to osteosclerosis by facilitating cortical mineral transfer to trabecular bone.
- An atypical form of osteomalacia in dialysis patients suggests a potential link to water-borne toxins.
Conclusions:
- Understanding the mechanisms of hypocalcaemia is crucial for managing renal bone disease.
- Osteosclerosis and atypical osteomalacia represent distinct skeletal manifestations in chronic renal failure and dialysis.
- Further investigation into water-borne toxins is warranted to address specific osteomalacia forms in dialysis patients.